Ctr-Simmons Compr. Cancer

Fingerprint

Dive into the research topics where Ctr-Simmons Compr. Cancer is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

Farjana Fattah
- farjana.fattah@utsouthwestern.edu
- Simmons Comprehensive Cancer Center - ASSISTANT PROFESSOR
- Ctr-Simmons Compr. Cancer - ASSISTANT PROFESSOR
Person: Academic
20042020
Ariella Hanker
- ariella.hanker@utsouthwestern.edu
- Simmons Comprehensive Cancer Center - ASSISTANT PROFESSOR
- Ctr-Simmons Compr. Cancer - ASSISTANT PROFESSOR
Person: Academic
20082020
Gang Huang
- gang.huang@utsouthwestern.edu
- Simmons Comprehensive Cancer Center - Assistant Professor
- Ctr-Simmons Compr. Cancer
Person: Academic
20032020

17 Article
4 Comment/debate
2 Review article

DC-HIL/GpNMB is a negative regulator of tumor response to immune checkpoint inhibitors
Chung, J. S., Ramani, V., Kobayashi, M., Fattah, F., Popat, V., Zhang, S., Cruz, P. D., Gerber, D. E. & Ariizumi, K., Mar 15 2020, In : Clinical Cancer Research. 26, 6, p. 1449-1459 11 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Detection of lymph node metastases by ultra-pH-sensitive polymeric nanoparticles
Bennett, Z. T., Feng, Q., Bishop, J. A., Huang, G., Sumer, B. D. & Gao, J., 2020, In : Theranostics. 10, 7, p. 3340-3350 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Erratum: Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers (Cancer Cell (2020) 37(2) (183–199.e5), (S1535610819305835), (10.1016/j.ccell.2019.12.013))
Sudhan, D. R., Guerrero-Zotano, A., Won, H., Ericsson, P. G., Servetto, A., Huerta-Rosario, M., Ye, D., Lee, K. M., Formisano, L., Guo, Y., Liu, Q., Kinch, L. N., Brewer, M. R., Dugger, T., Koch, J., Wick, M. J., Cutler, R. E., Lalani, A. S., Bryce, R., Auerbach, A. & 2 others, Hanker, A. B. & Arteaga, C. L., Feb 10 2020, In : Cancer Cell. 37, 2, p. 258-259 2 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
1 Scopus citations

Ctr-Simmons Compr. Cancer

Farjana Fattah

Ariella Hanker

Gang Huang

DC-HIL/GpNMB is a negative regulator of tumor response to immune checkpoint inhibitors

Detection of lymph node metastases by ultra-pH-sensitive polymeric nanoparticles

Erratum: Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers (Cancer Cell (2020) 37(2) (183–199.e5), (S1535610819305835), (10.1016/j.ccell.2019.12.013))